Individual Patient Compassionate Use of Crenolanib

Clinical trial NCT03620318 · AVAILABLE

Trial details

NCT number: NCT03620318
Sponsor: Arog Pharmaceuticals, Inc.
Status: AVAILABLE
Study type: EXPANDED_ACCESS

FLT3-ITD Mutation FLT3/TKD Mutation PDGFR-Alpha D842V PDGFRA Gene Amplification

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.